Pulmonary eosinophilia associated to treatment with natalizumab

Natalizumab (Tysabri(®)) is a leukocytes chemotaxis inhibitor that decreases the leukocytes passage through the hematoencephalic barrier and it is currently used in relapsing-remitting forms of multiple sclerosis (MS). We present a patient with allergic rhinoconjunctivitis diagnosed with MS who star...

Descripción completa

Detalles Bibliográficos
Autores principales: Curto, Elena, Munteis-Olivas, Elvira, Balcells, Eva, Domínguez-Álvarez, M. Marisol
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2016
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4966227/
https://www.ncbi.nlm.nih.gov/pubmed/27512514
http://dx.doi.org/10.4103/1817-1737.185762

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4966227/
https://www.ncbi.nlm.nih.gov/pubmed/27512514
http://dx.doi.org/10.4103/1817-1737.185762

Ejemplares similares